OtherBASIC SCIENCE INVESTIGATIONS
Lung Toxicity in Radioiodine Therapy of Thyroid Carcinoma: Development of a Dose-Rate Method and Dosimetric Implications of the 80-mCi Rule
George Sgouros, Hong Song, Paul W. Ladenson and Richard L. Wahl
Journal of Nuclear Medicine December 2006, 47 (12) 1977-1984;
George Sgouros
Hong Song
Paul W. Ladenson

Data supplements
Corrected PDF
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 47, Issue 12
December 2006
Lung Toxicity in Radioiodine Therapy of Thyroid Carcinoma: Development of a Dose-Rate Method and Dosimetric Implications of the 80-mCi Rule
George Sgouros, Hong Song, Paul W. Ladenson, Richard L. Wahl
Journal of Nuclear Medicine Dec 2006, 47 (12) 1977-1984;
Jump to section
Related Articles
Cited By...
- Diffuse Pneumonitis after Lutetium-177-PSMA-617 Treatment in a Patient with Metastatic Castration-Resistant Prostate Cancer
- MIRD Pamphlet No. 28, Part 1: MIRDcalc--A Software Tool for Medical Internal Radiation Dosimetry
- Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
- Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
- Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
- The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0
- Dosimetry and thyroid cancer: the individual dosage of radioiodine
- 124I PET-Based 3D-RD Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic Comparison
- MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry--Standardization of Nomenclature
- Lung Dosimetry for Radioiodine Treatment Planning in the Case of Diffuse Lung Metastases